Thyroid Function and Obesity: From Mechanisms to the Benefits of Levothyroxine in Obese Patients.
Level 5 - mechanism / opinion, no new human data
Narrative review of mechanisms and clinical literature without systematic search methodology
PubMed 33461477 · doi:10.2174/1871530321666210118162625
What was done
The authors conducted a narrative literature review evaluating the mechanistic links between thyroid hormone receptors, energy expenditure, and obesity, and assessing the potential role of levothyroxine therapy in euthyroid obese individuals.
What was found
No quantitative findings or effect sizes are reported in the abstract. Mechanistically, thyroid hormone receptor alpha (TRα) mediates thermogenesis and TRβ triggers uncoupling protein 1 (UCP1) expression. The authors found no clinical evidence supporting the use of thyroid hormones to treat obesity in euthyroid patients, concluding that levothyroxine should only be used for documented clinical or subclinical hypothyroidism.
Why it matters
It reinforces standard clinical practice against prescribing levothyroxine as a weight-loss intervention in euthyroid individuals despite the known metabolic mechanisms of thyroid hormones.
Limits
The abstract describes a narrative review without systematic search criteria, meta-analytic data, or quality appraisals. No patient counts, study numbers, or quantitative results are provided.
Cited by
- supports Hypothyroidism can reduce basal metabolic rate by up to 25%.